Reckitt Benckiser Group plc

Reckitt Benckiser Group plc

RBGPF
Reckitt Benckiser Group plcUS flagOther OTC
70.00
USD
- -
- -
44.45BMarket Cap
Reckitt Benckiser Group plc
RBGPF
(Other OTC)

Recent

price

70.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
12.16
13.58
13.76
13.44
12.77
12.96
14.02
16.98
18.59
18.88
20.5
19.31
21.05
21.23
21.07
21.78
13.61
Revenue per Share
2.26
2.5
2.62
2.52
4.66
2.55
2.71
9.15
3.19
-5.41
1.74
-0.05
3.39
2.39
2.12
4.88
2.5
Basic EPS, GAAP
1.68
2.2
2.46
2.75
2.77
2.34
3.01
3.18
3.08
1.42
4.44
1.82
2.85
3.18
3.3
2.58
2.5
Free Cash Flow per Basic Share
1.11
1.25
1.32
1.44
1.43
1.35
1.53
1.68
1.75
1.8
1.82
1.82
1.82
1.95
2.05
2.15
- -
Dividend per Share
7.26
8.16
8.58
9.17
9.9
10.16
12.53
20.01
21.68
13.74
13.32
10.79
13.36
12.32
10.16
12
8.16
Book Value per Share
-6.9
-6.5
-7.59
-6.96
-6.41
-6.46
-7.49
-23.64
-22.9
-21.87
-20.26
-16.72
-15.22
-14.79
-16.48
-12.49
-6.5
Tangible Book Value per Share
695
699
695
690
692
685
676
674
678
680
682
685
687
688
672
652
697
Basic Weighted Avg Shares
8,453
9,485
9,567
9,266
8,836
8,874
9,480
11,449
12,597
12,846
13,993
13,234
14,453
14,607
14,169
14,205
9,485
Sales/Revenue/Turnover
26.05
26.22
26.94
23.13
24.73
26.75
27.81
26.89
26.13
24.61
22.48
20.51
23.54
22.91
24.27
24.12
26.17
Operating Margin (%)
144
157
148
155
161
171
177
268
409
5,552
1,455
429
604
470
461
499
- -
Depreciation Expense
1,568
1,745
1,821
1,739
3,223
1,743
1,832
6,172
2,159
-3,683
1,187
-32
2,330
1,643
1,426
3,182
1,745
Net Income, GAAP
26.5
26.18
24.21
24.41
21.73
20.97
23.08
- -
19.71
- -
38.44
- -
23.18
31.36
31.94
16.55
26.18
Effective Tax Rate (%)
18.55
18.4
19.03
18.77
36.48
19.64
19.32
53.91
17.14
-28.67
8.48
-0.24
16.12
11.25
10.06
22.4
18.4
Profit Margin (%)
-3,099
-2,762
-3,406
-2,760
-2,129
-2,157
-1,951
-1,200
-2,717
-3,898
-1,624
-3,083
-3,056
-3,036
-3,345
-1,015
-2,762
Working Capital
3
3
3
598
636
671
804
11,797
9,950
8,545
9,794
7,078
7,163
6,858
7,235
7,620
3
LT Debt
5,130
5,781
5,922
6,336
6,834
6,906
8,426
13,557
14,771
9,407
9,159
7,453
9,483
8,469
6,720
7,781
5,781
Total Equity
25.46
21.92
21.67
17.21
17.97
19.6
19.89
- -
9.82
- -
9.28
- -
14.31
12.4
13.82
17.32
21.87
Return on Invested Capital (%)
26.39
21.89
21.21
19.32
35.2
18.96
18.56
- -
9.01
- -
6.49
- -
14.07
10.41
10.45
22.35
21.91
Return on Capital (%)
34.58
32.41
31.31
28.38
48.96
25.38
23.91
56.27
15.29
-30.58
12.85
-0.39
27.67
18.37
18.83
44.06
32.41
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
ST Debt
2,849
- -
2,505
LT Borrowings
3
- -
3
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
699
699
699
Market Capitalization
25,322
23,245
22,660

Working Capital

FRC

in mil. unless spec.
Jun'11
Sep'11
Dec'11
Total Current Assets
2,981
- -
2,938
Cash, Cash Equivalents & STI
581
- -
650
Accounts Receivable, Net
1,450
- -
1,247
Inventories
742
- -
758
Total Current Liabilities
6,191
- -
5,700
Payables & Accruals
- -
- -
- -
ST Debt
2,849
- -
2,505
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.6%
-1.39%
15.79%
Free Cash Flow
17.6%
-2.6%
-24.13%
Net Income, GAAP
-762.93%
-1,480.7%
123.14%
Sales/Revenue/Turnover
5.06%
0.42%
0.25%
Total Cash Common Dividend
4.33%
2.52%
1.59%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
14,607
2024
- -
- -
- -
- -
14,169
2025
- -
- -
- -
- -
14,205

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2.39
2024
- -
- -
- -
- -
2.12
2025
- -
- -
- -
- -
4.88

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1.95
2024
- -
- -
- -
- -
2.05
2025
- -
- -
- -
- -
2.15
Business
Reckitt Benckiser Group plc is a British multinational consumer goods company headquartered in Slough, United Kingdom, engaged in the manufacture and sale of health, hygiene, and nutrition products globally. Founded in 1999 through the merger of Reckitt & Colman plc and Benckiser NV, Reckitt organizes its business into three primary segments: Health, Hygiene, and Nutrition. Its Health segment includes over-the-counter (OTC) medicines, germ protection solutions, intimate wellness products, vitamins, minerals and supplements (VMS), and personal care items with flagship brands such as Mucinex, Strepsils, Gaviscon, Nurofen, and Biofreeze. The Hygiene segment covers surface and disinfection products, auto dishwash products, air care, fabric additives, lavatory care, and related categories with leading global brands including Lysol, Dettol, Harpic, Finish, and Vanish. The Nutrition segment offers infant and child nutrition products along with specialized nutritional solutions. Reckitt’s products are distributed across nearly 200 countries with a global network of distribution and embellishment centers. In major recent strategic developments, Reckitt has focused on sharpening its portfolio around high-growth and high-margin Powerbrands, divesting its Essential Home business, which includes home care brands like Cillit Bang and Calgon, to Advent International in 2025 while retaining a 30% equity stake, signaling a strategic shift toward a simpler, more focused consumer health and hygiene company. The company acquired the Biofreeze brand in 2021 to strengthen its presence in the pain relief category. Reckitt continues to drive innovation and market share growth in its core categories through product enhancements and sustained marketing investments, evidenced by strong growth in brands such as Lysol and Finish in 2024. These moves align with Reckitt’s strategy to focus on its top 19 most profitable brands, expected to generate 70% of net revenues, furthering its commitment to premium, high-growth segments with improved operational efficiency and shareholder value creation. Reckitt operates principally in the fast-moving consumer goods (FMCG) industry targeting retail consumers worldwide with a strong presence in the US, UK, China, and other key markets. The company employs over 35,000 people and maintains a robust global footprint with 131 distribution centers across 51 countries. Reckitt's strategic focus on health and hygiene, combined with its divestiture of non-core portfolios, positions the company to accelerate growth and margin expansion through leadership in consumer health, hygiene, and nutrition categories.

Company News

  • 3 Cheap International Stocks to Buy

  • Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk

  • Reckitt Benckiser Group H1 Earnings Call Highlights

  • Reckitt launches £500m buyback as quarterly sales accelerate

  • Reckitt beats second-quarter sales estimates on emerging markets strength

  • Reckitt Benckiser sells one of its two Russian units

  • Jefferies upgrades Reckitt to buy, arguing market has over-punished transitory setbacks

  • Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula

  • Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth

  • Swiss bank sees upside for Reckitt Benckiser though the Dettol and Durex owner needs to "rebuild trust"

  • Reckitt stock dips on Q1 miss: what's really ailing the health giant?

  • Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance

  • Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript

  • Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter

  • Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript

  • Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress

  • Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets

  • Reckitt Benckiser Group (OTCMKTS:RBGPF) Stock Price Down 0.3% – What’s Next?

  • Reckitt downgraded by RBC as Deutsche Bank strikes more bullish tone

  • Reckitt to pay £1.6bn special dividend after Essential Home sale